Rion is a clinical-stage biotechnology company That develops exosome therapeutics. Purified Exosome ProductTM (PEPTM) from Rion is a potent, useful, and easily available regenerative medicine. Research by Rion and its scientific partners has demonstrated the potential of PEP to repair a variety of injured tissue, including tendons, muscles, andskin. The goal of Rion is to spread the use of clinically effective regenerative medicine throughout the world.

Biotechnology

Rion

Atta Behfar

Laura Tucker (she, her)

Tony Wittnebel

Maureen Merrifield

Lindsey Rislow

Kevin Schiller

Chris Paradise, Ph.D.

Ben Boedeker, DVM, MD,PhD, MBA

Anna Eckerman

Alisa Lask

Alex Suihkonen

The Leadership Team at Rion is responsible for steering the company towards its mission of globalizing clinically effective regenerative medicine. This team defines strategic goals, oversees scientific research and product development, ensures regulatory compliance, drives commercial strategy, and fosters business growth and partnerships. They collectively guide the company in developing and commercializing Rion's Purified Exosome ProductTM (PEPTM) to repair injured tissues and improve patient outcomes worldwide.

Leadership Team

Directors and Senior Managers

Research and Development Team

Leadership Team

About

Team members

Other teams at Rion

Directors and Senior Managers

Research and Development Team